Lidorestat
Lidorestat (IDD-676) is an aldose reductase inhibitor (IC50: 5 nM) with effective, selective and oral activity. Lidorestat improves nerve conduction and reduces the formation of cataracts. Lidorestat can be used to treat complications of chronic diabetes.
Product Specifications
CAS Number
245116-90-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
376.35
Molecular Formula
C18H11F3N2O2S
Notes
Research use only, not for human use.
Receptor
Reductase
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
036382-HRP 200 µL
GUCA1C, CT (GUCA1C, GCAP3, Guanylyl cyclase-activating protein 3, Guanylate cyclase activator 1C) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details 